DIPROSPAN INJECTION

Product Information

Registration Status: Active

DIPROSPAN INJECTION is approved to be sold in Singapore with effective from 1990-06-22. It is marketed by MSD PHARMA (SINGAPORE) PTE LTD, with the registration number of SIN04759P.

This product contains Betamethasone Dipropionate 5mg/ml, and Betamethasone Phosphate 2mg/ml in the form of INJECTION. It is approved for INTRA-ARTICULAR, INTRABURSAL, INTRALESIONAL, PERIARTICULAR use.

This product is manufactured by SCHERING-PLOUGH LABO NV in BELGIUM.

It is a Prescription Only Medicine that can only be obtained from a doctor or a dentist, or a pharmacist with a prescription from a Singapore-registered doctor or dentist.

Betamethasone Dipropionate
Betamethasone Phosphate


Source of information: Drugbank (External Link). Last updated on: 3rd July 18. *Trade Name used in the content below may not be the same as the HSA-registered product.



Source of information: Drugbank (External Link). Last updated on: 3rd July 18. *Trade Name used in the content below may not be the same as the HSA-registered product.

References

  1. Health Science Authority of Singapore - Reclassified POM
  2. Drugbank